Our Approach to Holding Drug Companies Responsible On October 6, 2023, Siskinds LLP filed a proposed GLP-1 drug class action in the Supreme Court of British Columbia against Novo Nordisk and affiliated entities on behalf of persons in Canada who were prescribed and used Ozempic, Rybelsus, and/or Wegovy and suffered serious injuries
GLP-1 receptor agonists work by mimicking the action of naturally occurring GLP-1, a hormone that stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and promotes satiety
Instead of targeting the molecule, you build the conditions that allow it to appear naturally
Individuals with obesity or elevated weight-related risk Patients managing insulin resistance, prediabetes, or type 2 diabetes often see added benefits due to improved blood sugar control
The study was published Tuesday in the journal BMC Medicine